HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shu-Ping Hui Selected Research

Inflammation (Inflammations)

1/2022Quantitative Evaluation on the Degradation Process of the Pulmonary Surfactant Monolayer When Exposed to Low-Level Ozone of Ambient Environment.
10/2021Defining the kinetic effects of infection with influenza virus A/PR8/34 (H1N1) on sphingosine-1-phosphate signaling in mice by targeted LC/MS.
1/2021Sphingosine-1-phosphate interactions in the spleen and heart reflect extent of cardiac repair in mice and failing human hearts.
11/2020Low-Density Lipoprotein (LDL)-Triglyceride and Its Ratio to LDL-Cholesterol as Diagnostic Biomarkers for Nonalcoholic Steatohepatitis.
12/2019Identification of lead-produced lipid hydroperoxides in human HepG2 cells and protection using rosmarinic and ascorbic acids with a reference to their regulatory roles on Nrf2-Keap1 antioxidant pathway.
5/2014Serum choline plasmalogens, particularly those with oleic acid in sn-2, are associated with proatherogenic state.
3/2014[Analyses of lipid hydroperoxides and physiologically active lipids by mass spectrometry].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shu-Ping Hui Research Topics

Disease

7Inflammation (Inflammations)
01/2022 - 03/2014
5Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 02/2013
5Atherosclerosis
01/2019 - 03/2014
4Non-alcoholic Fatty Liver Disease
05/2022 - 11/2020
4Liver Diseases (Liver Disease)
03/2021 - 09/2012
3Neoplasms (Cancer)
03/2022 - 01/2019
3Insulin Resistance
09/2021 - 10/2019
3Hepatocellular Carcinoma (Hepatoma)
07/2021 - 07/2019
3Cholestasis
01/2019 - 07/2007
2Infections
09/2022 - 10/2021
2Metabolic Diseases (Metabolic Disease)
04/2022 - 09/2020
2Mitochondrial Diseases (Mitochondrial Disease)
10/2021 - 09/2021
2Fatty Liver
09/2021 - 03/2019
2Fibrosis (Cirrhosis)
03/2021 - 11/2020
2Heart Failure
11/2019 - 01/2014
2Metabolic Syndrome (Dysmetabolic Syndrome X)
10/2019 - 11/2014
2Alcoholic Fatty Liver
06/2019 - 10/2016
2Type 2 Diabetes Mellitus (MODY)
01/2019 - 10/2018
2Coronary Artery Disease (Coronary Atherosclerosis)
11/2014 - 11/2013
2Adenoma (Adenomas)
03/2014 - 09/2013
1Hyperammonemia
03/2021
1Muscle Cramp (Cramp)
03/2021
1Malnutrition (Nutritional Deficiencies)
03/2021
1Ischemia
01/2021
1Obesity
07/2020
1Breast Neoplasms (Breast Cancer)
01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
11/2019
1Body Weight (Weight, Body)
01/2017
1Dehydration (Water Stress)
03/2016
1Chronic Disease (Chronic Diseases)
07/2015
1Asthma (Bronchial Asthma)
07/2015
1Pneumonia (Pneumonitis)
07/2015
1Necrosis
06/2015

Drug/Important Bio-Agent (IBA)

10Triglycerides (Triacylglycerol)IBA
10/2021 - 07/2007
10Lipoproteins (Lipoprotein)IBA
10/2019 - 07/2007
8LipidsIBA
04/2022 - 05/2005
8oxidized low density lipoproteinIBA
11/2020 - 07/2007
7LDL Lipoproteins (beta Lipoproteins)IBA
11/2020 - 07/2007
5PlasmalogensIBA
10/2021 - 05/2014
4Biomarkers (Surrogate Marker)IBA
01/2022 - 11/2014
3lysophosphatidylethanolamineIBA
10/2021 - 10/2016
3AntioxidantsIBA
01/2020 - 06/2015
3HDL CholesterolIBA
10/2019 - 11/2014
2Volatile Fatty AcidsIBA
09/2022 - 01/2019
2Cardiolipins (Cardiolipin)IBA
10/2021 - 09/2021
2CytokinesIBA
10/2021 - 07/2015
2Biological ProductsIBA
10/2021 - 09/2020
2sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
10/2021 - 01/2021
2Fatty Acids (Saturated Fatty Acids)IBA
09/2021 - 06/2011
2Oleic Acid (Oleate)IBA
07/2021 - 11/2014
2Apolipoprotein L1IBA
12/2019 - 10/2019
2ApolipoproteinsIBA
01/2019 - 03/2008
2Ether (Diethyl Ether)IBA
03/2016 - 11/2014
2Apolipoproteins E (ApoE)IBA
02/2016 - 03/2008
2AldosteroneIBA
03/2014 - 09/2013
218-hydroxycortisolIBA
03/2014 - 09/2013
2Lipase (Acid Lipase)FDA Link
01/2014 - 07/2007
2Monoclonal AntibodiesIBA
09/2013 - 09/2012
2HDL LipoproteinsIBA
03/2008 - 07/2007
1dimethylethylenediamineIBA
09/2022
1Carbolines (Beta-Carbolines)IBA
05/2022
1flazinIBA
05/2022
1AlkaloidsIBA
05/2022
1Charcoal (Charbon)IBA
03/2022
1Phosphatidylethanolamines (Cephalins)IBA
10/2021
1SphingolipidsIBA
10/2021
1hydroxide ionIBA
09/2021
1Docosahexaenoic AcidsIBA
07/2021
112-hydroxy stearic acidIBA
07/2021
1EstersIBA
07/2021
1Branched-Chain Amino AcidsIBA
03/2021
1Carnitine (L-Carnitine)FDA LinkGeneric
03/2021
1Carbon Tetrachloride (Tetrachloromethane)IBA
03/2021
1LDL CholesterolIBA
11/2020
1low density lipoprotein triglycerideIBA
11/2020
1CadmiumIBA
01/2020
1XenobioticsIBA
01/2020
1VitaminsIBA
01/2020
1EnzymesIBA
01/2020
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2019
1CaprylatesIBA
11/2019
1GhrelinIBA
11/2019
1Ethanolamine (Colamine)IBA
07/2019
1Choline (Choline Chloride)IBA
07/2019
1NucleotidesIBA
03/2019
1Liposomes (Liposome)IBA
01/2019
1Phospholipids (Phosphatides)FDA LinkGeneric
10/2018
1tricaprinIBA
01/2017
1TinIBA
10/2016
1AcetoneIBA
03/2016
1lithium aluminum hydrideIBA
03/2016
1Oleic AcidsIBA
03/2016
1Indicators and Reagents (Reagents)IBA
03/2016
1CarbonIBA
07/2015
1DNA (Deoxyribonucleic Acid)IBA
06/2015
12,2'-azobis(2-amidinopropane) (ABAP)IBA
06/2015
1Glycerophospholipids (Phosphoglycerides)IBA
11/2014

Therapy/Procedure

2Heart Transplantation (Grafting, Heart)
11/2019 - 01/2014
1Therapeutics
11/2019
1Electrodes (Electrode)
01/2019